Insider Shareholders with Indirect Ownership of Xilio Therapeutics, Inc. (XLO)
This section provides a comprehensive overview of the insiders with indirect ownership of Xilio Therapeutics, Inc. (XLO). You can find the latest updates on their holdings.
Xilio Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | # of Trades |
|---|---|---|---|
|
Sv7 Impact Medicine Fund Lp
> 10% Shareholder |
1,301,132 | 0 | 1 |
| 1,881,355 | 0 | 1 | |
|
James E Flynn
> 10% Shareholder |
2,287,944 | 0 | 1 |
|
Takeda Pharmaceutical Co Ltd
> 10% Shareholder |
1,475,121 | 0 | 1 |
| 218,705 | 0 | 1 | |
|
Rock Springs Capital Management Lp
> 10% Shareholder |
1,407,766 | 0 | 1 |
|
Bain Capital Life Sciences Investors, Llc
> 10% Shareholder |
42,469 | 0 | 3 |
|
Atlas Venture Fund Xi, L.P.
> 10% Shareholder |
2,733,029 | 1,396 | 4 |
|
Bay City Capital Llc
> 10% Shareholder |
1,129,490 | 0 | 1 |
|
River Vest Venture Fund Iv, L.P.
> 10% Shareholder |
1,441,444 | 0 | 1 |
|
K Ga A Merck
> 10% Shareholder |
680,825 | 0 | 1 |